We are 3-triethoxysilylpropyl thiocyanate CAS:34708-08-2 manufacturer and supplier in China, Pls send inquiry of to email@example.com of visit www.nbinno.com our official website should you have any interests
Chemical Name:3-triethoxysilylpropyl thiocyanate
Synonyms:3-Thiocyanatopropyltriethoxysilane; 3-Thiocyanatopropyltri-aethoxysilan; 3-Thiocyanatopropyltriethoxysilan;
Physical and Chemical Properties:
Index of Refraction:1.446;
Appearance:Straw to yellowish liquid with mild odor
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:It can improve reinforcing properties of flers that contain hydroxyl groups.
IT can improve physical and mechanical properties of vulcanizates. It can improve tensile strength, tearing strength and abrasive resistance and reduce compression set of vulcanizates. In addition, it can reduce the viscosity and improve the processability of rubber products.
Related News: This means that the drug attributes of the drug substance will be lost in the future, and the monopoly power of some drug substances will also be lost. The preparation company will become the main person in charge of the drug. The drug preparation company will be responsible for the quality of the original excipients. It will be more cautious, some raw and auxiliary materials companies whose quality cannot be guaranteed will be gradually eliminated, and the industry concentration will be further improved.89466-08-0 At the same time, through years of imitation and advanced technology learning, more and more domestic companies have participated in the field of highly original and characteristic APIs.(Metiltio) metilpirazina CAS:67952-65-2 The glucagon-only configuration may be helpful in rare conditions that often lead to chronic, low blood-sugar conditions, such as congenital hyperinsulinism (CHI).3-bromo-2-cloro-5-metilpiridina CAS:17282-03-0 Complete the research and development of APIs and intermediates, design new patented process routes, and explore new crystal forms.The Company’s immuno-oncology product candidates include natural killer (NK) cell and T-cell cancer immunotherapies, which are designed to synergize with well-established cancer therapies, including immune checkpoint inhibitors and monoclonal antibodies, and to target tumor-associated antigens with chimeric antigen receptors (CARs).